// App-Quantinova.ai

2110 : Allogeneic Hematopoietic Stem Cell Transplantation Is Feasible After Solid Organ Transplantation: A Retrospective Analysis By The Early Complications Subcommittee Of The Complications and Quality Of Life Working Party, EBMT

Researchers

Presenter

  • Grzegorz W. Basak

Principal Investigators

  • Wieslaw Wiktor Jedrzejczak

  • Helene Schoemans

  • Mohamad Mohty

  • Theo de Witte

  • Judith Marsh

  • Peter Dreger

  • Nicolaus Kroeger

  • Rafael F. Duarte

  • Tapani Ruutu

  • Per T. Ljungman

  • Guido Kobbe

  • Yves Beguin

  • Peter Lang

  • Karl-Walter Sykora

  • Liane CJ te Boome

  • Anja van Biezen

  • Steffie van der Werf

Medical Centers

  • Clinical Hematology, Catalan Institute of Oncology, Barcelona, Spain

  • Department of General Pediatrics, Hematology/Oncology, University Childrens Hospital, Tuebingen, Germany

  • Centre for allogeneic stem cell transplantation (CAST), Karolinska University Hospital,

  • University Hospital Gasthuisberg, Leuven, Belgium

  • Medizinische Klinik und Poliklinik V, Universitatsklinikum, Heidelberg, Germany

  • Dept. of Hematology, UMCU, Utrecht, Netherlands

  • Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warszawa, Poland

  • Department of Urology, King's College Hospital NHS Foundation Trust, London, United Kingdom

  • Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warszawa, Poland

  • University Medical Center St Radboud, Nijmegen, Netherlands

  • Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany

  • Center of Oncology - Bone Marrow Transplantation Unit, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Department of Medical Statistics, Leiden University Medical Center, Leiden, Netherlands

  • University Central Hospital, Helsinki, Finland

  • Haematology, CHU of Liege and University of Liege, Liege, Belgium

  • EBMT Leyden Office, Leyden, The Netherlands,

  • Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Duesseldorf, Medical Faculty, Duesseldorf, Germany

  • department of hematology and cell therapy, hopital Saint-Antoine, EBMT Acute Leukemia Working Party and Registry, Hospital Saint-Antoine, Paris University, Paris, France

Locations

  • Finland

  • Netherlands

  • Poland

  • Spain

  • Germany

  • Sweden

  • United Kingdom

  • France

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Urology

Disease

  • Dilated cardiomyopathy

  • Primary sclerosing cholangitis

  • Liver cancer

  • Diabetic nephropathy

  • Fulminant hepatic failure

  • Glomerulonephritis

  • Acute Leukemia

  • Renal insufficiency

  • Heart muscle disease

  • Pyelonephritis

  • Renal disease

  • Viral myocarditis

  • Ascending cholangitis

  • Cirrhosis

  • Lymphomas

  • Solid malignancies

  • Graft-versus-host disease

Biomarkers

  • N/A

Drug/Treatment

  • Cyclosporine A

  • Mycophenolic acid

  • Cyclosporine eent

  • Methotrexate

  • Tacrolimus

  • Mofezolac

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved